Showing results (111-120 of 121) with videos related to
Sort By:
Pageof 13
Annales De Dermatologie Et De Venereologie|January 1, 1993
[Streptococcus beta hemolytic necrotizing fasciitis. 5 cases in the Brussels area]T Simonart, J M Simonart, C Schoutens, et al.The Journal of International Medical Research|April 12, 2006
Decreased immunoreactive maspin expression in intermediate thickness and thick primary melanoma lesionsP Vereecken, S Reynaert, M C Lalmand, et al.Journal of Virological Methods|August 15, 1998
PCR assay fails to detect molluscum contagiosum virus-related sequences in AIDS-related Kaposi's sarcomaT Simonart, J C Noël, J P Van Vooren, et al.Archives of Dermatological Research|October 16, 2007
Skin biopsies in DC vaccines for stage III-IV melanoma patients: role of neutrophils?M Laporte, M Trakatelli, P Vereecken, et al.BMC Dermatology|August 24, 2001
Cultured Kaposi's sarcoma tumor cells exhibit a chemokine receptor repertoire that does not allow infection by HIV-1T Simonart, C Debussher, C Liesnard, et al.The British Journal of Dermatology|December 1, 1995
Proliferating cell nuclear antigen distribution in verrucous carcinoma of the skinJ C Noel, M Heenen, M O Peny, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|June 15, 2007
Impact of cosmetic care on quality of life in breast cancer patients during chemotherapy and radiotherapy: an initial randomized controlled studyG Titeca, F Poot, D Cassart, et al.Clinical and Experimental Dermatology|November 29, 2005
High serum galectin-3 in advanced melanoma: preliminary resultsP Vereecken, K Zouaoui Boudjeltia, C Debray, et al.Archives of Dermatological Research|June 24, 2009
Time-kinetic study of repigmentation in vitiligo patients by tacrolimus or pimecrolimusL J Lubaki, G Ghanem, P Vereecken, et al.Vaccine|December 12, 2001
Immunologic and virologic response after tetanus toxoid booster among HIV-1- and HIV-2-infected Senegalese individualsT N Dieye, P S Sow, T Simonart, et al.Pageof 13